Kurs
+0,83%
Likviditet
2,29 MSEK
Prenumeration
Kalender
Tid* | ||
2026-01-21 | 08:00 | Bokslutskommuniké 2025 |
2025-10-22 | 08:00 | Kvartalsrapport 2025-Q3 |
2025-07-31 | 08:00 | Kvartalsrapport 2025-Q2 |
2025-05-15 | N/A | X-dag ordinarie utdelning FLERIE 0.00 SEK |
2025-05-14 | N/A | Årsstämma |
2025-04-16 | 08:00 | Kvartalsrapport 2025-Q1 |
2025-01-22 | - | Bokslutskommuniké 2024 |
2024-10-16 | - | Kvartalsrapport 2024-Q3 |
2024-07-17 | - | Kvartalsrapport 2024-Q2 |
2024-07-12 | - | Split FLERIE 100:1 |
2024-05-14 | - | Årsstämma |
2024-05-08 | - | X-dag ordinarie utdelning FLERIE 0.00 SEK |
2024-04-15 | - | Kvartalsrapport 2024-Q1 |
2024-01-24 | - | Bokslutskommuniké 2023 |
2023-11-28 | - | Kvartalsrapport 2023-Q3 |
2023-08-23 | - | Kvartalsrapport 2023-Q2 |
2023-05-24 | - | Årsstämma |
2023-05-24 | - | Kvartalsrapport 2023-Q1 |
2023-05-08 | - | X-dag ordinarie utdelning FLERIE 0.00 SEK |
2023-02-23 | - | Bokslutskommuniké 2022 |
2022-11-23 | - | Kvartalsrapport 2022-Q3 |
2022-08-26 | - | Kvartalsrapport 2022-Q2 |
2022-06-02 | - | X-dag ordinarie utdelning FLERIE 0.00 SEK |
2022-06-01 | - | Årsstämma |
2022-05-16 | - | Kvartalsrapport 2022-Q1 |
2022-02-23 | - | Bokslutskommuniké 2021 |
2021-11-24 | - | Kvartalsrapport 2021-Q3 |
2021-08-25 | - | Kvartalsrapport 2021-Q2 |
2021-06-04 | - | X-dag ordinarie utdelning FLERIE 0.00 SEK |
2021-06-03 | - | Årsstämma |
2021-05-05 | - | Kvartalsrapport 2021-Q1 |
2021-02-25 | - | Bokslutskommuniké 2020 |
2021-01-12 | - | Extra Bolagsstämma 2020 |
2020-11-25 | - | Kvartalsrapport 2020-Q3 |
2020-08-26 | - | Kvartalsrapport 2020-Q2 |
2020-05-07 | - | Kvartalsrapport 2020-Q1 |
2020-04-21 | - | X-dag ordinarie utdelning FLERIE 0.00 SEK |
2020-04-20 | - | Årsstämma |
2020-02-20 | - | Bokslutskommuniké 2019 |
2019-11-27 | - | Kvartalsrapport 2019-Q3 |
2019-10-09 | - | Extra Bolagsstämma 2019 |
2019-08-15 | - | Kvartalsrapport 2019-Q2 |
2019-05-07 | - | X-dag ordinarie utdelning FLERIE 0.00 SEK |
2019-05-06 | - | Årsstämma |
2019-05-06 | - | Kvartalsrapport 2019-Q1 |
2019-02-20 | - | Bokslutskommuniké 2018 |
2018-11-19 | - | Kvartalsrapport 2018-Q3 |
2018-08-28 | - | Kvartalsrapport 2018-Q2 |
2018-05-25 | - | X-dag ordinarie utdelning FLERIE 0.00 SEK |
2018-05-24 | - | Årsstämma |
2018-05-17 | - | Kvartalsrapport 2018-Q1 |
2018-02-26 | - | Bokslutskommuniké 2017 |
2017-11-17 | - | Kvartalsrapport 2017-Q3 |
2017-08-25 | - | Kvartalsrapport 2017-Q2 |
2017-05-31 | - | X-dag ordinarie utdelning FLERIE 0.00 SEK |
2017-05-30 | - | Årsstämma |
2017-05-30 | - | Kvartalsrapport 2017-Q1 |
2017-02-27 | - | Bokslutskommuniké 2016 |
2016-11-22 | - | Kvartalsrapport 2016-Q3 |
Beskrivning
Land | Sverige |
---|---|
Lista | Mid Cap Stockholm |
Sektor | Hälsovård |
Industri | Bioteknik |
Flerie AB's Nomination Committee for the Annual General Meeting 2025 has been appointed based on the ownership structure as of September 30, 2024. In accordance with the principles for the Nomination Committee, the members of the Nomination Committee of Flerie AB should be appointed by the three largest shareholders, as per September 30, 2024. In addition, the Chairman of the Board shall be a member of the Nomination Committee. The Nomination Committee is responsible for preparing and presenting proposals for the chairman, the members of the board, the board compensation, the audit fees, and the election of auditors.
As per September 30, the three largest shareholders constituted of Thomas Eldered representing T&M Participation AB and T&M Förvaltning AB (75.4% of the votes and share capital), the Fourth Swedish National Pension Fund (7.0%), Cajelo Invest Ltd (2.5%). The three largest shareholders represent 84.9 percent of the voting rights for all shares of Flerie AB and have appointed the following members to the nomination committee:
- Thomas Eldered appointed by T&M Participation AB and T&M Förvaltning AB
- Jannis Kitsakis appointed by the Fourth Swedish National Pension Fund
- Lars Backsell appointed by Cajelo Invest Ltd
Thomas Eldered is also adjunct in his role as the Chairman of the Board.
The Annual General Meeting 2025 will be held on May 14, 2025, in Stockholm, Sweden. Shareholders who would like to submit proposals to the Nomination Committee can do so by e-mail to nomination.committee@flerie.com. Proposals have to be received no later than February 28, 2025, to be considered by the Nomination Committee.
Flerie in brief
Flerie is an active long-term life science investor, with a broad and diversified portfolio of innovative companies based on pioneering science. We invest in product development and commercial growth opportunities globally alongside other leading investors, focusing predominantly on private companies that are otherwise difficult to access. Flerie’s active ownership model, broad network and resources support and accelerate the development of the portfolio projects, creating value for shareholders. Flerie AB’s ordinary share is listed on Nasdaq Stockholm with the ticker FLERIE. For further information please visit www.flerie.com